Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE)

American Journal of Medicine

Volumn 127, Issue 6, 2014, Pages 503-511

  Park, Kay Lee ^a   Goldberg, Robert J ^a   Anderson, Frederick A ^a   López Sendón, José ^b   Montalescot, Gilles ^c   Brieger, David ^d   Eagle, Kim A ^e   Wyman, Allison ^a   Gore, Joel M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Clinical outcomes; Intravenous beta blockers; Oral beta blockers; ST elevation myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART FAILURE; ADULT; ARTICLE; CARDIOGENIC SHOCK; CORONARY REPERFUSION; DRUG DOSAGE FORM COMPARISON; DRUG USE; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; INFERIOR MYOCARDIAL INFARCTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; THERAPY DELAY; TREATMENT OUTCOME;

CLINICAL OUTCOMES; INTRAVENOUS BETA-BLOCKERS; ORAL BETA-BLOCKERS; ST-ELEVATION MYOCARDIAL INFARCTION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPENSITY SCORE; REGISTRIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901390129     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.02.009     Document Type: Article

References (23)

1. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
2. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results JAMA 247 1982 1707 1714
3. S.S. Gottlieb, R.J. McCarter, and R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497 (Pubitemid 28384881)
4. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
5. A. Hjalmarson, D. Elmfeldt, and J. Herlitz et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial Lancet 2 1981 823 827 (Pubitemid 11017550)
6. R.M. Norris, P.F. Barnaby, and M.A. Brown et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol Lancet 2 1984 883 886 (Pubitemid 15201128)
7. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial N Engl J Med 320 1989 618 627
8. M. Pfisterer, J.L. Cox, and C.B. Granger et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries J Am Coll Cardiol 32 1998 634 640 (Pubitemid 28435246)
9. R. Roberts, W.J. Rogers, and H.S. Mueller et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
10. F. Van de Werf, L. Janssens, and T. Brzostek et al. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy J Am Coll Cardiol 22 1993 407 416 (Pubitemid 23214552)
11. Z.M. Chen, H.C. Pan, and Y.P. Chen et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
12. The GRACE Investigators Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes Am Heart J 141 2001 190 199
13. J. Lopez-Sendon, K. Swedberg, and J. McMurray et al. Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
14. F. Van de Werf, J. Bax, and A. Betriu et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
15. E.M. Antman, M. Hand, and P.W. Armstrong et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
16. C.B. Granger, R.J. Goldberg, and O. Dabbous et al. Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345 2353 (Pubitemid 37310196)
17. L. Ryden, R. Ariniego, and K. Arnman et al. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias N Engl J Med 308 1983 614 618 (Pubitemid 13152324)
18. A. Al-Reesi, N. Al-Zadjali, and J. Perry et al. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis CJEM 10 2008 215 223
19. N. Freemantle, J. Cleland, and P. Young et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737 (Pubitemid 29290470)
20. J. Edwards, S.G. Goodman, and R.T. Yan et al. Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early beta-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 161 2011 291 297
21. K.A. Fox, P.G. Steg, and K.A. Eagle et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900 (Pubitemid 46707843)
22. R.F. Gillum Trends in acute myocardial infarction and coronary heart disease death in the United States J Am Coll Cardiol 23 1994 1273 1277 (Pubitemid 24157993)
23. H. Silvet, F. Spencer, and J. Yarzebski et al. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study Arch Intern Med 163 2003 2175 2183 (Pubitemid 37248782)